Human Genome Epidemiology Literature Finder
Records 1 - 24 (of 24 Records) |
Query Trace: Breast Neoplasms and CD4[original query] |
---|
Combinational polymorphisms of seven CXCL12-related genes are protective against breast cancer in Taiwan. Omics : a journal of integrative biology 2009 Apr 13 (2): 165-72. Lin Gau-Tyan, Tseng Hung-Fu, Yang Cheng-Hong, Hou Ming-Feng, Chuang Li-Yeh, Tai Hsiao-Ting, Tai Ming-Hong, Cheng Yu-Huei, Wen Cheng-Hao, Liu Chih-Shan, Huang Chih-Jen, Wang Chun-Lin, Chang Hsueh-W |
Functional polymorphism rs7072793 C > T affect individual susceptibility to breast cancer by modulating CD25 transcription activity. Molecular carcinogenesis 2013 May 52 (5): 370-6. Li Hongbin, Zhou Hongfeng, Zhang Qingyuan, Zhao Shu, Zhang Yue, Wang Yan, Liu Jinglei, Song Ying, Yu Xiaojin, Yu Y |
IL-21 gene polymorphism is associated with the prognosis of breast cancer in Chinese populations. Breast cancer research and treatment 2013 Jan . You Y, Deng J, Zheng J, Hu M, Li N, Wu H, Li W, Lu J, Zhou Y |
Apoptosis for prediction of radiotherapy late toxicity: lymphocyte subset sensitivity and potential effect of TP53 Arg72Pro polymorphism. Apoptosis : an international journal on programmed cell death 2015 Mar 20 (3): 371-82. Fuentes-Raspall María J, Caragol Isabel, Alonso Carmen, Ramón y Cajal Teresa, Fisas David, Seoane Alejandro, Carvajal Nerea, Bonache Sandra, Díez Orland, Gutiérrez-Enríquez Sa |
Pertuzumab, trastuzumab and eribulin mesylate therapy for previously treated advanced HER2-positive breast cancer: a feasibility study with analysis of biomarkers. Oncotarget 2018 3 9 (19): 14909-14921. Tono Yasutaka, Ishihara Mikiya, Miyahara Yoshihiro, Tamaru Satoshi, Oda Hiroyasu, Yamashita Yoshiki, Tawara Isao, Ikeda Hiroaki, Shiku Hiroshi, Mizuno Toshiro, Katayama Naoyu |
Mutation and immune profiling of metaplastic breast cancer: Correlation with survival. PloS one 2019 14 (11): e0224726. Afkhami Michelle, Schmolze Daniel, Yost Susan E, Frankel Paul H, Dagis Andrew, Amanam Idoroenyi U, Telatar Milhan, Nguyen Kim, Yu Kim Wai, Luu Thehang, Pillai Raju, Aoun Patricia A, Mortimer Joanne, Yuan Yu |
Systematic Analysis of Coronavirus Disease 2019 (COVID-19) Receptor ACE2 in Malignant Tumors: Pan-Cancer Analysis. Frontiers in molecular biosciences 2020 11 7 569414. Song Jukun, Han Jing, Liu Feng, Chen Xianlin, Qian Shenqi, Wang Yadong, Jia Zhenyu, Duan Xiaofeng, Zhang Xiangyan, Zhu Jiang |
Abundance of Regulatory T Cell (Treg) as a Predictive Biomarker for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer. Cancers 2020 10 12 (10): . Oshi Masanori, Asaoka Mariko, Tokumaru Yoshihisa, Angarita Fernando A, Yan Li, Matsuyama Ryusei, Zsiros Emese, Ishikawa Takashi, Endo Itaru, Takabe Kazua |
Tumour-infiltrating CD4-, CD8- and FOXP3-positive immune cells as predictive markers of mortality in BRCA1- and BRCA2-associated breast cancer. British journal of cancer 2021 Aug . Jørgensen Nanna, Hviid Thomas Vauvert F, Nielsen Lise B, Sønderstrup Ida M H, Eriksen Jens Ole, Ejlertsen Bent, Gerdes Anne-Marie, Kruse Torben A, Thomassen Mads, Jensen Maj-Britt, Lænkholm Anne-Vibe |
Heparanase is a novel biomarker for immune infiltration and prognosis in breast cancer. Aging 2021 8 13 (16): 20836-20852. Yang Wen-Jing, Shi Lin, Wang Xiao-Min, Yang Guo-Wa |
mA RNA Methylation Regulator YTHDF1 Correlated With Immune Microenvironment Predicts Clinical Outcomes and Therapeutic Efficacy in Breast Cancer. Frontiers in medicine 2021 8 8 667543. Hu Ying, Pan Qinwen, Wang Minghao, Ai Xiang, Yan Yuzhao, Tian Yuan, Jing Yuting, Tang Peng, Jiang J |
Bioinformatic Analysis of Immune Significance of RYR2 Mutation in Breast Cancer. BioMed research international 2021 12 2021 8072796. Xu Zhiquan, Xiang Ling, Wang Rong, Xiong Yongfu, Zhou He, Gu Haitao, Wang Jijian, Peng Linglo |
MELK expression in breast cancer is associated with infiltration of immune cell and pathological compete response (pCR) after neoadjuvant chemotherapy. American journal of cancer research 2021 10 11 (9): 4421-4437. Oshi Masanori, Gandhi Shipra, Huyser Michelle R, Tokumaru Yoshihisa, Yan Li, Yamada Akimitsu, Matsuyama Ryusei, Endo Itaru, Takabe Kazua |
An enhancer variant associated with breast cancer susceptibility in Black women regulates TNFSF10 expression and antitumor immunity in triple-negative breast cancer. Human molecular genetics 2022 8 32 (1): 139-150. Han Yoo Jane, Zhang Jing, Hardeman Ashley, Liu Margaret, Karginova Olga, Romero Roger, Khramtsova Galina F, Zheng Yonglan, Huo Dezheng, Olopade Olufunmilayo |
Multidimensional Molecular Profiling of Metastatic Triple-Negative Breast Cancer and Immune Checkpoint Inhibitor Benefit. JCO precision oncology 2022 7 6 e2100413. Barroso-Sousa Romualdo, Forman Juliet, Collier Katharine, Weber Zachary T, Jammihal Tejas R, Kao Katrina Z, Richardson Edward T, Keenan Tanya, Cohen Ofir, Manos Michael P, Brennick Ryan C, Ott Patrick A, Hodi F Stephen, Dillon Deborah A, Attaya Victoria, O'Meara Tess, Lin Nancy U, Van Allen Eliezer M, Rodig Scott, Winer Eric P, Mittendorf Elizabeth A, Wu Catherine J, Wagle Nikhil, Stover Daniel G, Shukla Sachet A, Tolaney Sara |
Amino Acid Metabolism-Related lncRNA Signature Predicts the Prognosis of Breast Cancer. Frontiers in genetics 2022 6 13 880387. Dai Yin-Wei, Wen Zhi-Kai, Wu Zhi-Xuan, Wu Hao-Dong, Lv Lin-Xi, Yan Cong-Zhi, Liu Cong-Hui, Wang Zi-Qiong, Zheng Ch |
Abundance of reactive oxygen species (ROS) is associated with tumor aggressiveness, immune response, and worse survival in breast cancer. Breast cancer research and treatment 2022 5 194 (2): 231-241. Oshi Masanori, Gandhi Shipra, Yan Li, Tokumaru Yoshihisa, Wu Rongrong, Yamada Akimitsu, Matsuyama Ryusei, Endo Itaru, Takabe Kazua |
Prognostic value of tumor mutation burden and the relationship between tumor mutation burden and immune infiltration in HER2+ breast cancer: a gene expression-based study. Gland surgery 2022 3 11 (1): 100-114. Wen Ying, Ouyang Dengjie, Chen Qitong, Zeng Liyun, Luo Na, He Hongye, Anwar Munawar, Qu Limeng, Zou Qiongyan, Yi Wenj |
System Analysis of Adaptor-Related Protein Complex 1 Subunit Mu 2 (AP1M2) on Malignant Tumors: A Pan-Cancer Analysis. Journal of oncology 2022 2 2022 7945077. Yi Yuanxue, Zhang Qiufang, Shen Youfeng, Gao Yueyi, Fan Xiaohong, Chen Sini, Ye Xin, Xu Ji |
Efficacy and exploratory biomarker analysis of entinostat plus exemestane in advanced or recurrent breast cancer: phase II randomized controlled trial. Japanese journal of clinical oncology 2022 11 53 (1): 4-15. Iwata Hiroji, Nakamura Rikiya, Masuda Norikazu, Yamashita Toshinari, Yamamoto Yutaka, Kobayashi Kokoro, Tsurutani Junji, Iwasa Tsutomu, Yonemori Kan, Tamura Kenji, Aruga Tomoyuki, Tokunaga Eriko, Kaneko Koji, Lee Min-Jung, Yuno Akira, Kawabata Azusa, Seike Toshihiro, Kaneda Ayumi, Nishimura Yozo, Trepel Jane B, Saji Shigehi |
Immune cells are increased in normal breast tissues of BRCA1/2 mutation carriers. Breast cancer research and treatment 2022 11 197 (2): 277-285. Ogony Joshua, Hoskin Tanya L, Stallings-Mann Melody, Winham Stacey, Brahmbhatt Rushin, Arshad Muhammad Asad, Kannan Nagarajan, Peña Alvaro, Allers Teresa, Brown Alyssa, Sherman Mark E, Visscher Daniel W, Knutson Keith L, Radisky Derek C, Degnim Amy |
Genomic properties and clinical outcomes associated with tertiary lymphoid structures in patients with breast cancer. Scientific reports 2023 8 13 (1): 13542. Liye Wang, Shuai Gong, Lina Pang, Shengli Zhang, Xiaoke Zhang, Wei |
The mutation and low expression of ARID1A are predictive of a poor prognosis and high immune infiltration in triple-negative breast cancer. Current cancer drug targets 2023 5 . Yuejing Wang, Zhuo Chen, Jing Wu, Hong Yan, Yiran Wang, Jie |
Elucidating cuproptosis-related gene SLC31A1 diagnostic and prognostic values in cancer. American journal of translational research 2023 11 15 (10): 6026-6041. Jiaoping Mi, Juncong Luo, Huanwen Zeng, Hongyu Zhang, Muhammad Jamil, Mostafa A Abdel-Maksoud, Adel M Zakri, Akram A Alfuraydi, Ning Zhang, Mei Xi |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: